OHLCX Market Research
Delayed

CRL

Charles River Laboratories provides essential products and services to the pharmaceutical and biotechnology industries, focusing on drug development and discovery.

−12.50 (−3.81%) Nov 20, 2026 19:43 ET Delayed
Open
324.98
High
327.23
Low
310.52
Prev close
327.93
Volume
1M
Avg vol 10
790K

Today · Market closed · opens Mon 9:30 AM

Price

CRL chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 315.43

Strong sellNeutralStrong buy
Sell
score −0.22 · 18 signalling
2Buy
10Neutral
6Sell

Leaning sell. 6 of 18 signals point down against 2 up, carried by trend. Momentum is mostly neutral. Volatility is mostly neutral. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory.

How to read this →

Trend

MACD 12, 26, 9
Below signal line, still above zero
MACD 2.02 · Signal 6.53 · Hist −4.50
Sell
ADX 14
Developing trend, −DI slightly ahead
ADX 21.75 · +DI 22.48 · −DI 26.49
Sell
Parabolic SAR 0.02, 0.2
Above price, 38.93 over the close
354.36
Sell
Ichimoku 9, 26, 52
Price above cloud, conversion below base
Conv 333.26 · Base 337.99 · A 305.57 · B 280.91
Neutral

Momentum

RSI 14
Mid-range, no extreme
42.91
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 10.18 · %D 24.18
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K just crossed under %D
%K 13.66 · %D 16.58
Neutral
Williams %R 14
Oversold zone, falling
−89.82
Neutral
CCI 14
Below −100, still falling
−169.13
Neutral
MFI 14
Below midpoint, not oversold
43.74
Neutral
ROC 12
Price down 3.33% over 12 bars
−3.33%
Sell
AO 5, 35
Above zero, falling
2.18
Neutral
TRIX 18
Above zero
0.392
Buy
KST 10/15/20/30, 3
Below its signal line
KST 70.38 · Signal 85.98
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.09
Up 376.01 · Mid 342.89 · Low 309.76
Neutral
Keltner 20, 10, 1.5
Inside the channel, lower half
Up 356.18 · Mid 333.20 · Low 310.23
Neutral

Volume

VWAP 345-bar
Close 50.1% above VWAP
210.19
Buy
Force Index 1
Negative, sellers in control
−14.4M
Sell
ATR
15.32
4.86% of close
A/D Line
18.6M
cumulative
OBV
6.4M
cumulative
Volume Profile
161.07 – 177.88
POC · bull 72.0M · bear 46.8M · 61 / 39
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-7.46%

Change in value over the past month.

3 month return

5.27%

Change in value over the last three months.

Max drawdown

33.88%

Largest fall from a peak to the low that followed.

Standard deviation

49.37%

How far daily returns stray from their average, annualised.

Sharpe ratio

1.25

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.82

Annualised return against the maximum drawdown.

About

CRL summary

Loading summary…

Questions

CRL, answered

Who are Charles River Laboratories’ main competitors?

Competitors include Covance, WuXi AppTec, and Charles River’s other service providers in the life sciences sector.

What do analysts say about CRL stock?

Analysts provide insights based on market trends and financial reports; check recent analyst reports for evaluations.

What factors influence CRL stock price?

Factors include industry demand for preclinical and clinical services, regulatory changes, and overall market conditions.

Where can I find news about Charles River Laboratories?

News can be found on financial news websites, Charles River Laboratories’ investor relations page, and industry-specific publications.

Is CRL a good long-term investment?

To determine if CRL is a good long-term investment, consider industry trends, financial health, and growth potential.

How can I buy CRL stock?

You can purchase CRL shares through online brokerage accounts or through traditional brokers.

What risks should I consider when investing in CRL?

Consider risks such as changes in healthcare regulations, market competition, and dependency on the pharmaceutical sector.

Does Charles River Laboratories pay dividends?

Charles River Laboratories does not currently pay dividends, focusing on reinvesting in growth opportunities.

What is the market capitalization of Charles River Laboratories?

The market capitalization of Charles River Laboratories typically ranges in the billions; check financial sites for up-to-date values.

What recent developments have impacted CRL stock?

Recent developments include mergers and acquisitions, changes in regulatory environments, and quarterly earnings reports.

News

CRL in the news

Reveal Your CRL Trading Now

Empower your trading with OHLCX.com. Our comprehensive platform delivers precise analysis and strategic insights for CRL, designed to improve your trading outcomes. Elevate your trading approach instantly and unlock new opportunities with our advanced system!

Discover More Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.